{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:28:49Z","timestamp":1773235729722,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.genhosppsych.2010.10.004","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T09:32:30Z","timestamp":1291455150000},"page":"84.e3-84.e4","source":"Crossref","is-referenced-by-count":6,"title":["The real mechanism of VPA-induced hyperammonemia remains unknown"],"prefix":"10.1016","volume":"33","author":[{"given":"Chung-Chieh","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin-May","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0005","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/appi.ajp.164.7.1020","article-title":"Hyperammonemia due to valproic acid in the psychiatric setting","volume":"164","author":"Carr","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/YIC.0b013e3281c61b28","article-title":"Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting","volume":"22","author":"Dealberto","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0015","first-page":"851","article-title":"Phenotype and genotype analyses of ornithine transcarbamylase deficiency in Taiwanese","volume":"102","author":"Huang","year":"2003","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s001340100937","article-title":"Simultaneous side effects of both clozapine and valproate","volume":"27","author":"Nicolai","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0269881109102635","article-title":"Clinical alertness to valproic acid-induced hyperammonemia\u2014two case reports","volume":"24","author":"Shan","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2009.04.002","article-title":"The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status","volume":"86","author":"Hamed","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0040","first-page":"314","article-title":"Hyperammonemia in valproate therapy in children and adolescents","volume":"57","author":"Laub","year":"1986","journal-title":"Nervenarzt"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs","volume":"29","author":"Verrotti","year":"1999","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.genhosppsych.2010.10.004_bb0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3476(05)83396-7","article-title":"Muscle carnitine deficiency in patients using valproic acid","volume":"118","author":"Shapiro","year":"1991","journal-title":"J Pediatr"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834310002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834310002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T11:53:17Z","timestamp":1544097197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834310002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0163834310002008"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2010.10.004","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}